Nashville, TN (PRWEB) July 08, 2015 -- Medelis, Inc., a specialty oncology CRO, today announced that David Fox, former President and CEO of Praxis, has joined the company in the role of Vice President, Client Services.
David has a broad range of clinical research experience ranging from clinical pharmacology through Phase IV Registration studies. With over 30 years of healthcare and CRO experience, David was co-founder of Praxis, a leading patient recruitment company located in Nashville, TN. He served as President and Chief Executive Officer until it was sold in 2010.
“We are in an aggressive growth phase here at Medelis,” says Bill Taaffe, President of Medelis. “David will be an integral part of that growth going forward. We are excited to have him on board.”
In addition to a nursing degree from the University of Tennessee, David holds a BS, Biology degree from Lipscomb University. He will be operating out of Medelis’ clinical operations office located in Nashville, TN.
Medelis is a specialty oncology CRO focused on phase I through phase III oncology trials in North America and Europe. Founded in 2003, Medelis provides sponsors with oncology expertise from drug development thought-leadership to a highly skilled clinical operations team, handling complex oncology trials in all indications including cutting-edge immunotherapy treatments.
Jim, Medelis, http://www.medelis.com, +1 480-445-9141, [email protected]